Deborah Lehrer
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Pathology and Forensic Medicine top 10%
- Cancer Mechanisms and Therapy
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Oncology 11
- Colorectal Cancer Treatments and Studies 4
- Cancer Treatment and Pharmacology 3
- Co-authors
- Jonathan D. SchwartzJohn MandeliE. CohenAllyson J. OceanAlec GoldenbergE PopaSean Clark-GarveyShahin Rafii
- Journals
- Journal of Clinical Oncology (10 papers)Journal of Pharmacy and Pharmacology (2 papers)Clinical Cancer Research (1 paper)European Journal of Cancer (1 paper)Journal of Clinical Gastroenterology (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Deborah Lehrer
20 papers receiving 686 citations
Peers
Comparison fields: 5 of 72
- Hepatology 365
- Pathology and Forensic Medicine 195
- Oncology 240
- Cancer Research 128
- Immunology 117
Countries citing papers authored by Deborah Lehrer
This map shows the geographic impact of Deborah Lehrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Lehrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Lehrer more than expected).
Fields of papers citing papers by Deborah Lehrer
This network shows the impact of papers produced by Deborah Lehrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Lehrer. The network helps show where Deborah Lehrer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Deborah Lehrer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 97 | |
| 2 | 2017 | 0 | |
| 3 | 2014 | 1 | |
| 4 | Phase 1 study of intravenous rigosertib (ON 01910.Na), a novel benzyl styryl sulfone structure producing G2/M arrest and apoptosis, in adult patients with advanced cancer. | 2013 | 18 |
| 5 | 2011 | 4 | |
| 6 | 2010 | 10 | |
| 7 | 2008 | 2 | |
| 8 | 2008 | 379 | |
| 9 | 2006 | 38 | |
| 10 | 2006 | 11 | |
| 11 | 2005 | 24 | |
| 12 | 2005 | 17 | |
| 13 | 2004 | 16 | |
| 14 | 2004 | 2 | |
| 15 | 2002 | 9 | |
| 16 | 1993 | 22 | |
| 17 | 1992 | 8 | |
| 18 | 1965 | 10 | |
| 19 | 1963 | 19 | |
| 20 | 1962 | 2 |
About Deborah Lehrer
Deborah Lehrer is a scholar working on Hepatology, Oncology, Cancer Research, Hematology and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 706 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (3 papers), Cancer Genomics and Diagnostics (3 papers), Renal cell carcinoma treatment (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Multiple and Secondary Primary Cancers (2 papers). The work is most often cited by research in Hepatology (365 citations), Pathology and Forensic Medicine (195 citations), Oncology (240 citations), Cancer Research (128 citations) and Immunology (117 citations). Deborah Lehrer has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Jonathan D. Schwartz, John Mandeli, E. Cohen, Allyson J. Ocean, Alec Goldenberg, E Popa, Sean Clark-Garvey, Shahin Rafii, Abby B. Siegel and Alan Weinberg. Their work appears in journals such as Journal of Clinical Oncology, Journal of Pharmacy and Pharmacology, Clinical Cancer Research, European Journal of Cancer and Journal of Clinical Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.